Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 + 631 word(s) 631 2020-12-15 07:34:43

Video Upload Options

Do you have a full video?

Confirm

Are you sure to Delete?
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Xu, R. Pearson Marrow-Pancreas Syndrome. Encyclopedia. Available online: https://encyclopedia.pub/entry/5192 (accessed on 23 June 2024).
Xu R. Pearson Marrow-Pancreas Syndrome. Encyclopedia. Available at: https://encyclopedia.pub/entry/5192. Accessed June 23, 2024.
Xu, Rita. "Pearson Marrow-Pancreas Syndrome" Encyclopedia, https://encyclopedia.pub/entry/5192 (accessed June 23, 2024).
Xu, R. (2020, December 24). Pearson Marrow-Pancreas Syndrome. In Encyclopedia. https://encyclopedia.pub/entry/5192
Xu, Rita. "Pearson Marrow-Pancreas Syndrome." Encyclopedia. Web. 24 December, 2020.
Pearson Marrow-Pancreas Syndrome
Edit

Pearson marrow-pancreas syndrome is a severe disorder that usually begins in infancy.

genetic conditions

1. Introduction

It causes problems with the development of blood-forming (hematopoietic) cells in the bone marrow that have the potential to develop into different types of blood cells. For this reason, Pearson marrow-pancreas syndrome is considered a bone marrow failure disorder. Function of the pancreas and other organs can also be affected.

Most affected individuals have a shortage of red blood cells (anemia), which can cause pale skin (pallor), weakness, and fatigue. Some of these individuals also have low numbers of white blood cells (neutropenia) and platelets (thrombocytopenia). Neutropenia can lead to frequent infections; thrombocytopenia sometimes causes easy bruising and bleeding. When visualized under the microscope, bone marrow cells from affected individuals may appear abnormal. Often, early blood cells (hematopoietic precursors) have multiple fluid-filled pockets called vacuoles. In addition, red blood cells in the bone marrow can have an abnormal buildup of iron that appears as a ring of blue staining in the cell after treatment with certain dyes. These abnormal cells are called ring sideroblasts.

In people with Pearson marrow-pancreas syndrome, the pancreas does not work as well as usual. The pancreas produces and releases enzymes that aid in the digestion of fats and proteins. Reduced function of this organ can lead to high levels of fats in the liver (liver steatosis). The pancreas also releases insulin, which helps maintain correct blood sugar levels. A small number of individuals with Pearson marrow-pancreas syndrome develop diabetes, a condition characterized by abnormally high blood sugar levels that can be caused by a shortage of insulin. In addition, affected individuals may have scarring (fibrosis) in the pancreas.

People with Pearson marrow-pancreas syndrome have a reduced ability to absorb nutrients from the diet (malabsorption), and most affected infants have an inability to grow and gain weight at the expected rate (failure to thrive). Another common occurrence in people with this condition is buildup in the body of a chemical called lactic acid (lactic acidosis), which can be life-threatening. In addition, liver and kidney problems can develop in people with this condition.

About half of children with this severe disorder die in infancy or early childhood due to severe lactic acidosis or liver failure. Many of those who survive develop signs and symptoms later in life of a related disorder called Kearns-Sayre syndrome. This condition causes weakness of muscles around the eyes and other problems.

2. Frequency

Pearson marrow-pancreas syndrome is a rare condition; its prevalence is unknown.

3. Causes

Pearson marrow-pancreas syndrome is caused by defects in mitochondria, which are structures within cells that use oxygen to convert the energy from food into a form cells can use. This process is called oxidative phosphorylation. Although most DNA is packaged in chromosomes within the nucleus (nuclear DNA), mitochondria also have a small amount of their own DNA, called mitochondrial DNA (mtDNA). This type of DNA contains many genes essential for normal mitochondrial function. Pearson marrow-pancreas syndrome is caused by single, large deletions of mtDNA, which can range from 1,000 to 10,000 DNA building blocks (nucleotides). The most common deletion, which occurs in about 20 percent of affected individuals, removes 4,997 nucleotides.

The mtDNA deletions involved in Pearson marrow-pancreas syndrome result in the loss of genes that provide instructions for proteins involved in oxidative phosphorylation. These deletions impair oxidative phosphorylation and decrease the energy available to cells. It is not clear how loss of mtDNA leads to the specific signs and symptoms of Pearson marrow-pancreas syndrome, although the features of the condition are likely related to a lack of cellular energy.

4. Inheritance

Pearson marrow-pancreas syndrome is generally not inherited but arises from new (de novo) mutations that likely occur in early embryonic development.

5. Other Names for This Condition

  • Pearson syndrome

References

  1. Manea EM, Leverger G, Bellmann F, Stanescu PA, Mircea A, Lèbre AS, Rötig A,Munnich A. Pearson syndrome in the neonatal period: two case reports and reviewof the literature. J Pediatr Hematol Oncol. 2009 Dec;31(12):947-51. doi:10.1097/MPH.0b013e3181bbc4ef. Review.
  2. Rötig A, Bourgeron T, Chretien D, Rustin P, Munnich A. Spectrum ofmitochondrial DNA rearrangements in the Pearson marrow-pancreas syndrome. Hum MolGenet. 1995 Aug;4(8):1327-30.
  3. Sadikovic B, Wang J, El-Hattab AW, Landsverk M, Douglas G, Brundage EK,Craigen WJ, Schmitt ES, Wong LJ. Sequence homology at the breakpoint and clinicalphenotype of mitochondrial DNA deletion syndromes. PLoS One. 2010 Dec20;5(12):e15687. doi: 10.1371/journal.pone.0015687. Erratum in: PLoS One. 2017Nov 20;12 (11):e0188610.
  4. Tumino M, Meli C, Farruggia P, La Spina M, Faraci M, Castana C, Di Raimondo V,Alfano M, Pittalà A, Lo Nigro L, Russo G, Di Cataldo A. Clinical manifestationsand management of four children with Pearson syndrome. Am J Med Genet A. 2011Dec;155A(12):3063-6. doi: 10.1002/ajmg.a.34288.
More
Information
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
View Times: 344
Entry Collection: MedlinePlus
Revision: 1 time (View History)
Update Date: 24 Dec 2020
1000/1000
Video Production Service